In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

Scope of the Report:
The global IVD Infectious Diseases market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of IVD Infectious Diseases.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the IVD Infectious Diseases market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the IVD Infectious Diseases market by product type and applications/end industries.

Market Segment by Companies, this report covers
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Alere
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Immunochemistry
Molecular Diagnostics

Market Segment by Applications, can be divided into
Clinical Laboratories
Diagnostic Centers